What does L-Carnosine do?

Antioxidant dipeptide with early research in brain health and tissue repair, but most human evidence is limited.

Most human trials are very small (3 patients in the MS pilot study) or show null results — marketing often overstates the evidence

L-Carnosine - Science-Based Research

What the Science Says

L-Carnosine is a naturally occurring dipeptide (two amino acids joined together) found in muscle and brain tissue. It acts as an antioxidant and anti-inflammatory agent, and early clinical research suggests it may modestly improve attention and executive function in certain neurological conditions at doses around 800 mg/day. As zinc-L-carnosine (polaprezinc), it has shown some benefit for oral mucositis (mouth sores from cancer treatment) and may support fracture healing, though most human trials are small or preliminary.

What It Doesn't Do

Not proven to treat autism spectrum disorder — a randomized controlled trial found no significant improvement in autism symptoms. Not a proven anti-aging supplement despite heavy marketing around that claim. Won't reliably improve schizophrenia negative symptoms based on current trial data. Topical polaprezinc mouthwash did not prevent severe oral mucositis in stem cell transplant patients in one large randomized trial. No human evidence it burns fat or builds muscle. Cancer-related findings are purely lab-based — do not interpret this as a cancer treatment.

Evidence-Based Benefits

L-Carnosine is a naturally occurring dipeptide (two amino acids joined together) found in muscle and brain tissue. It acts as an antioxidant and anti-inflammatory agent, and early clinical research suggests it may modestly improve attention and executive function in certain neurological conditions at doses around 800 mg/day. As zinc-L-carnosine (polaprezinc), it has shown some benefit for oral mucositis (mouth sores from cancer treatment) and may support fracture healing, though most human trials are small or preliminary.

Weak Evidence

Effective at: 400-2000 mg daily (varies by condition; no universal established dose)

Source: auto-research

Absorption & Bioavailability

Unknown from provided studies — oral forms are used in trials but no pharmacokinetic data was provided. L-Carnosine is known to be rapidly broken down by carnosinase enzymes in blood, which may limit systemic availability; topical and specialized delivery systems (proposomes, hya-ascorposomes) are being explored to address this.

Red Flags to Watch For

Most human trials are very small (3 patients in the MS pilot study) or show null results — marketing often overstates the evidence
Zinc-L-carnosine (polaprezinc) is a different compound from pure L-carnosine; products may conflate the two without distinguishing their separate evidence bases
Cancer-related claims (radiosensitizer, PAR2 modulator) are based on animal models and computational studies only — no human cancer trials provided
Rapid breakdown by carnosinase enzymes in the body means standard oral doses may not reach target tissues at effective concentrations
501 registered supplement products exist despite very limited high-quality human clinical evidence — widespread commercial use outpaces the science

Research Sources

PubMed
NIH DSLD